# Study Evaluating the Pharmacokinetics of Keppra Extended Release (XR) in Children and Adults With Epilepsy

> **NCT00961441** · PHASE2 · COMPLETED · sponsor: **UCB BIOSCIENCES, Inc.** · enrollment: 25 (actual)

## Conditions studied

- Epilepsy

## Interventions

- **DRUG:** Keppra XR

## Key facts

- **NCT ID:** NCT00961441
- **Lead sponsor:** UCB BIOSCIENCES, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-09
- **Primary completion:** 2010-03
- **Final completion:** 2010-03
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2015-08-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00961441

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00961441, "Study Evaluating the Pharmacokinetics of Keppra Extended Release (XR) in Children and Adults With Epilepsy". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00961441. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*